【 Instant Release 】 World Graphene Industry Federation: Medical Technology Special Conference Facilitates Tian 'an Technology to join hands with EpiMedTech Global to create a new model of preventive medicine

On July 17, 2025, the World Graphene Federation (WGF for short) held a "Special Conference on the Application of Frontier Medical Technologies" in Hong Kong. Professor Feng Guanping, the chairperson of the World Graphene Industry Federation, and Professor Moshe Szyf both attach great importance to the future cooperation between the two sides, in order to promote Tian 'an Technology Group (OTC number in the United States: TANAF and EpiMedTech Global have collaborated and jointly announced that both sides will take "ultra-early, light diagnosis, and rapid physical therapy" as the core direction, actively expand in-depth cooperation in the field of preventive medical technology, and jointly build a new health management model integrating traditional Chinese medicine wisdom and epigenetics.

As the founder of the graphene field in China and the chairman of WGF, Feng Guanping stated at the conference: The in-depth communication with EpiMedTech is very encouraging. In the future, we expect to build on Tian 'an Technology's graphene health preservation technology and combine it with EpiMedTech's DNA methylation detection system to jointly create a comprehensive health solution that focuses on prevention, emphasizes personalized management and long-term health tracking.

This collaboration can be regarded as a model of the integration of traditional wisdom and modern technology, and will set a new benchmark for the field of health management.

Yang Hengfei, the chairman of Tian 'an Technology Group and the president of the World Graphene Industry Federation, introduced that the group has been deeply engaged in the research and development of high-tech health products centered on single-layer graphene for many years, integrating the traditional Chinese medicine health preservation concept of "harmonizing Yin and Yang, promoting blood circulation and unblocking meridians, and balancing the five internal organs" into it. The technology it has developed, through non-invasive graphene light waves, can stimulate the human immune and repair mechanisms, promote blood circulation and energy balance, and has been widely applied in many health centers in Hong Kong and the Chinese mainland. EpiMedTech Global was founded by Professor Moshe Szyf, an international authority on epigenetics. It is one of the earliest enterprises in the world to apply DNA methylation detection technology in the field of preventive medicine. Its core technology can be used for early risk screening of diseases such as cancer. Support health early warning through precise analysis of DNA methylation data.

Both sides have clearly defined four core cooperation directions:

First, upgrade the health center and integrate the products. The epigenetic testing service has been fully introduced into the health centers under Tian 'an Technology as an assessment tool and data tracking method before, during and after the treatment course, providing a scientific basis for health management.

Second, jointly carry out market promotion. Both sides will join hands to promote the brand in Hong Kong, the Chinese mainland and overseas markets, highlighting the innovative model of "Traditional Chinese Medicine health preservation × genetic technology", and exploring new markets in preventive medicine.

Thirdly, promote clinical research and scientific verification. Jointly promote relevant clinical and research projects, evaluate the actual effects of graphene intervention on indicators such as physiological age and cancer risk, and accelerate the wide application of the results in clinical practice in accordance with international standards.

Fourth, achieve deep integration of digital platforms. The epiLife App under EpiMedTech will be fully integrated into Tian 'an Technology's customer service system, providing users with personalized health advice and scientific tracking services.

Professor Moshe Szyf said, "We very much welcome this cooperation. Enabling people to prevent problems before they occur is the common goal of both sides." Health is the most precious asset in life. Our scientific research aims to identify potential health risks before diseases occur and provide practical technological tools for the public.

Tang Qiuru, the vice chairman of Tian 'an Group, believes: "The cooperation between Tian 'an Technology and EpiMedTech will be of great significance in the future. We look forward to leveraging the platform advantages of the World Graphene Industry Federation, combined with policy support and commercial, financial, technological and market resources, to achieve complementary advantages and common development for both sides."

Regarding the future development of the World Graphene Industry Federation, Yang Hengfei stated that the federation hopes to rely on the platform, integrate Hong Kong's capital advantages, scientific research strength and international market network, and promote the standardization, industrialization and scale development of graphene in the global medical and health industry. Nowadays, graphene technology has moved from the laboratory to practical applications. In the future, efforts will be made to build a full-chain ecosystem from genetic testing, disease prevention and intervention to community health management, and to create a global health technology industry system with graphene at its core.